Tryptophan reduces the degree of brown adipose tissue whitening in rats with visceral obesity
DOI:
https://doi.org/10.15584/ejcem.2024.4.29Keywords:
brown adipose tissue, obesity, tryptophanAbstract
Introduction and aim. The relationship between brown adipose tissue (BAT) and visceral obesity (VO) is a topic of growing interest in scientific and medical research. The aim of this work was to investigate the effect of L-tryptophan on histomorpho logical abnormalities in BAT induced by a high calorie diet (HCD).
Material and methods. The study was performed on male Wistar rats 3 months of age. Control rats (group I) were fed a stan dard diet. VO in animals (groups II and III) was modelled by exposure to an HCD (45% fat and 31% carbohydrates) for 12 weeks. The rats in group III were also given L-tryptophan (80 mg/kg). Histological preparations were prepared from the interscapular bodies of the BAT. Indicators of lipid metabolism, oxygen consumption, subcutaneous oxygen tension and basal temperature were measured in the rats.
Results. It was found that the group of rats on HCD lead to the development of VO, and histomorphological changes occur in BAT indicating a decrease in its activity. Supplementation with L-tryptophan reduced the structural abnormalities in BAT, name ly the accumulation of fat, the whitening of brown adipocytes, and prevented excessive loss of activity due to the deleterious effects of HCD.
Conclusion. Supplementation with L-tryptophan may have a potential benefit in preventing the development of excessive VO by preserving BAT activity.
Supporting Agencies
The work was performed as part of the state assignment “Bogomoletz Institute of Physiology” (No.0119U103965).Downloads
References
Malik VS, Willet WC, Hu FB. Nearly a decade on – trends, risk factors and policy implications in global obesity. Nat Rev Endocrinol. 2020;16:615-616. doi: 10.1038/s41574-020-00411-y
Fruh SM. Obesity: risk factors, complications, and strategies for sustainable long-term weight management. J Am Assoc Nurse Pract. 2017;29(1):S3-S14. doi: 10.1002/2327-6924.12510
Liu X, Zhang Z, Song Y, Xie H, Dong M. An update on brown adipose tissue and obesity intervention: Function, regulation and therapeutic implications. Front Endocrinol. 2023;13:1065263. doi: 10.3389/fendo.2022.1065263
Kulterer OC, Herz CT, Prager M, et al. Brown adipose tissue prevalence is lower in obesity but its metabolic activity is intact. Front Endocrinol. 2022;13:858417. doi: 10.3389/fendo.2022.858417
U-Din M, de Mello VD, Tuomainen M, et al. Cold-stimulated brown adipose tissue activation is related to changes in serum metabolites relevant to NAD+ metabolism in humans. Cell Rep. 2023;42(9):113131. doi: 10.1016/j.celrep.2023.113131
Zhu Y, Qi Z, Ding S. Exercise-induced adipose tissue thermogenesis and browning: how to explain the conflicting findings? Int J Mol Sci. 2022;23(21):13142. doi: 10.3390/ijms232113142
Okla M, Kim J, Koehler K, Chung S. Dietary factors promoting brown and beige fat development and thermogenesis. Adv Nutr. 2017;8(3):473-483. doi: 10.3945/an.116.014332
Kimura H, Nagoshi T, Oi Y, et al. Treatment with atrial natriuretic peptide induces adipose tissue browning and exerts thermogenic actions in vivo. Sci Rep. 2021;11(1):17466. doi: 10.1038/s41598-021-96970-9
Zhu T, Chen X, Jiang S. Progress and obstacles in transplantation of brown adipose tissue or engineered cells with thermogenic potential for metabolic benefits. Front Endocrinol (Lausanne). 2023;14:1191278. doi: 10.3389/fendo.2023.1191278
Lischka J, Schanzer A, Baumgartner M, de Gier C, Greber-Platzer S, Zeyda M. Tryptophan metabolism is associated with BMI and adipose tissue mass and linked to metabolic disease in pediatric obesity. Nutrients. 2022;14(2):286. doi: 10.3390/nu14020286
Shipelin VA, Trusov NV, Apryatin SA, et al. Effects of tyrosine and tryptophan in rats with diet-induced obesity. Int J Mol Sci. 2021;22;24-29. doi: 10.3390/ijms22052429
Kesić M, Baković P, Farkaš V, et al. Constitutive serotonin tone as a modulator of brown adipose tissue thermogenesis: A rat study. Life. 2023;13(7):1436. doi: 10.3390/life13071436
Xu L, Li D, Li H, et al. Suppression of obesity by melatonin through increasing energy expenditure and accelerating lipolysis in mice fed a high-fat diet. Nutr Diabetes. 2022;12(1):42. doi: 10.1038/s41387-022-00222-2
Halpern B, Mancini MC, Bueno C, et al. Melatonin increases brown adipose tissue volume and activity in patients with melatonin deficiency: A proof-of-concept study. Diabetes. 2019;68(5):947-952. doi: 10.2337/db18-0956
Heraief E, Burckhardt P, Wurtman J, Wurtman RJ. Tryptophan administration may enhance weight loss by some moderately obese patients on a protein-sparing modified fast (PSMF) diet. International Journal of Eating Disorders. 1985;4(3):281-292.
Cavaliere H, Medeiros-Neto G. The anorectic effect of increasing doses of L-tryptophan in obese patients. Eat Weight Disord. 1997;2:211-215. doi: 10.1007/BF03339978
Wang W, Wang X, Liu L, et al. Dietary tryptophan and the risk of obesity and type 2 diabetes: Total effect and mediation effect of sleep duration. Obesity (Silver Spring). 2022;30(2):515-523. doi: 10.1002/oby.23343
Yanko R, Levashov M, Chaka OG, Nosar V, Khasabov SG, Khasabova I. Tryptophan prevents the development of non-alcoholic fatty liver disease. Diabetes Metab Syndr Obes. 2023;16:4195-4204. doi: 10.2147/DMSO.S444278
Yanko RV, Zinchenko AS, Chaka OG, Levashov MI. Method of modeling alimentary fatty liver disease in laboratory rats. Ukraine patent No. 150511. 2022 Feb 23.
Rehfeld A, Nylander M, Karnov K. Histological Methods. In: Compendium of Histology. Springer, Cham; 2017. doi: 10.1007/978-3-319-41873-5_2
Cinti S, Zingaretti MC, Cancello R, Ceresi E, Ferrara P. Morphologic techniques for the study of brown adipose tissue and white adipose tissue. Methods Mol Biol. 2001;155:21-51. doi: 10.1385/1-59259-231-7:021
Shinde AB, Song A, Wang QA. Brown adipose tissue heterogeneity, energy metabolism, and beyond. Front Endocrinol. 2021;12:651763. doi: 10.3389/fendo.2021.651763
Yuko OO, Saito M. Brown fat as a regulator of systemic metabolism beyond thermogenesis. Diabetes Metab J. 2021;45(6):840-852. doi: 10.4093/dmj.2020.0291
Landsberg L, Young JB, Leonard WR, Linsenmeier RA, Turek FW. Do the obese have lower body temperatures? A new look at a forgotten variable in energy balance. Trans Am Clin Climatol Assoc. 2009;120:287-295.
Khanna D, Khanna S, Khanna P, Kahar P, Patel BM. Obesity: A chronic low-grade inflammation and its markers. Cureus. 2022;14(2):e22711. doi: 10.7759/cureus.22711
Lumeng CN. Innate immune activation in obesity. Mol Aspects Med. 2013;34(1):12-29. doi: 10.1016/j.mam.2012.10.002
Benador IY, Veliova M, Mahdaviani K, et al. Mitochondria bound to lipid droplets have unique bioenergetics, composition, and dynamics that support lipid droplet expansion. Cell Metab. 2018;27(4):869-885. doi: 10.1016/j.cmet.2018.03.003
Jung SM, Sanchez-Gurmaches J, Guertin DA. Brown adipose tissue development and metabolism. Handb Exp Pharmacol. 2019;251:3-36. doi: 10.1007/164_2018_168
Ziqubu K, Dludla PV, Mthembu SXH, et al. An insight into brown/beige adipose tissue whitening, a metabolic complication of obesity with the multifactorial origin. Front Endocrinol. 2023;14:1114767. doi: 10.3389/fendo.2023.1114767
Kotzbeck P, Giordano A, Mondini E, et al. Brown adipose tissue whitening leads to brown adipocyte death and adipose tissue inflammation. J Lipid Res. 2018;59(5):784-794. doi: 10.1194/jlr.M079665
Blázquez-Medela AM, Jumabay M, Rajbhandari P, et al. Noggin depletion in adipocytes promotes obesity in mice. Mol Metab. 2019;25:50-63. doi: 10.1016/j.molmet.2019.04.004
Lou P, Bi X, Tian Y, et al. MiR-22 modulates brown adipocyte thermogenesis by synergistically activating the glycolytic and mTORC1 signaling pathways. Theranostics. 2021;11(8):3607-3623. doi: 10.7150/thno.50900
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
